Study Evaluating the Efficacy of Hydroxychloroquine and Azithromycine in Patients With COVID-19 and Hematological Malignancies (HYACINTHE)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The primary objective of this phase 2, multicentric, placebo-controlled double-blind, randomized study is to evaluate the efficacy of the combination of hydroxychloroquine and azithromycine on the viral load drop at day 5 among patients with COVID-19 and hematological malignancies.
Epistemonikos ID: 5edb4b8167dc73b2b19a29f8d6923407802b78e0
First added on: May 19, 2020